LX7101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LX7101, covering 2015-09-14 to 2015-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]